Home
>
National Drug Code (NDC)
>
ELOXATIN
ELOXATIN - 12516-0592-4 - (oxaliplatin)
Drug Information of ELOXATIN
| Product NDC: | 12516-0592 |
| Proprietary Name: | ELOXATIN |
| Non Proprietary Name: | oxaliplatin |
| Active Ingredient(s): | 5 mg/mL & nbsp; oxaliplatin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ELOXATIN
| Product NDC: | 12516-0592 |
| Labeler Name: | Aventis Pharma Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021759 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090722 |
Package Information of ELOXATIN
| Package NDC: | 12516-0592-4 |
| Package Description: | 240 VIAL, SINGLE-USE in 1 CASE (12516-0592-4) > 40 mL in 1 VIAL, SINGLE-USE |
NDC Information of ELOXATIN
| NDC Code | 12516-0592-4 |
| Proprietary Name | ELOXATIN |
| Package Description | 240 VIAL, SINGLE-USE in 1 CASE (12516-0592-4) > 40 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 12516-0592 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxaliplatin |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090722 |
| Marketing Category Name | NDA |
| Labeler Name | Aventis Pharma Ltd. |
| Substance Name | OXALIPLATIN |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
